PT1776133E - Agonistas peptídicos de receptor da vasopressina - Google Patents

Agonistas peptídicos de receptor da vasopressina Download PDF

Info

Publication number: PT1776133E
Authority: PT; Portugal
Prior art keywords: receptor agonists; vasopressin receptor; peptidic vasopressin; peptidic; agonists
Prior art date: 2004-08-11

Application number

PT05783076T

Other languages

English (en)

Inventor

Kazimierz Wisniewski

Claudio Schteingart

Regent Laporte

Robert Felix Galyean

Pierre J-M Riviere

Original Assignee

Ferring Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-11

Filing date

2005-08-03

Publication date

2011-09-02

2005-08-03 Application filed by Ferring Bv filed Critical Ferring Bv

2011-09-02 Publication of PT1776133E publication Critical patent/PT1776133E/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Cardiology (AREA)
Biochemistry (AREA)
Heart & Thoracic Surgery (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Epidemiology (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Diabetes (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Pulmonology (AREA)
Ophthalmology & Optometry (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PT05783076T 2004-08-11 2005-08-03 Agonistas peptídicos de receptor da vasopressina PT1776133E (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US60037704P	2004-08-11	2004-08-11
EP04019029		2004-08-11

Publications (1)

Publication Number	Publication Date
PT1776133E true PT1776133E (pt)	2011-09-02

Family

ID=34926126

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT05783076T PT1776133E (pt)	2004-08-11	2005-08-03	Agonistas peptídicos de receptor da vasopressina

Country Status (25)

Country	Link
US (2)	US8148319B2 (pt)
EP (1)	EP1776133B1 (pt)
JP (1)	JP4664363B2 (pt)
KR (1)	KR100884323B1 (pt)
CN (1)	CN1964732B (pt)
AR (1)	AR050914A1 (pt)
AT (1)	ATE509944T1 (pt)
AU (1)	AU2005274070B2 (pt)
BR (1)	BRPI0511466B8 (pt)
CA (1)	CA2567797C (pt)
DK (1)	DK1776133T3 (pt)
ES (1)	ES2366702T3 (pt)
IL (1)	IL178690A (pt)
JO (1)	JO2937B1 (pt)
MX (1)	MX2007001396A (pt)
NO (1)	NO342449B1 (pt)
NZ (1)	NZ550707A (pt)
PL (1)	PL1776133T3 (pt)
PT (1)	PT1776133E (pt)
RU (1)	RU2355701C2 (pt)
SA (1)	SA05260254B1 (pt)
SI (1)	SI1776133T1 (pt)
TW (1)	TWI364291B (pt)
WO (1)	WO2006020491A1 (pt)
ZA (1)	ZA200700772B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JO2937B1 (en) *	2004-08-11	2016-03-15	فيرينغ.بي.في	Tight muscles of the peptide vascular tensioner receptor
RU2415149C2 (ru) *	2006-02-10	2011-03-27	Ферринг Б.В.	Пептидные соединения
SI1984012T1 (sl) *	2006-02-13	2016-05-31	Ferring B.V.	Uporaba peptidnih agonistov receptorja vazopresina
EP2175874A2 (en)	2007-08-14	2010-04-21	Ferring B.V.	Use of peptidic vasopressin receptor agonists
ES2629131T3 (es)	2008-09-17	2017-08-07	Chiasma Inc.	Composiciones farmacéuticas y métodos de suministro relacionados.
JO3109B1 (ar)	2012-05-10	2017-09-20	Ferring Bv	منبهات لمستقبلات v1a
US9388214B2 (en)	2014-11-05	2016-07-12	Ferring B.V.	V1A receptor agonists
RU2634272C1 (ru) *	2016-08-10	2017-10-24	Закрытое акционерное общество "Санкт-Петербургский институт фармации"	Композиция с дезамино-аргинин-вазотоцином для парентерального введения и способ её получения
ES3023754T3 (en)	2016-10-21	2025-06-03	Amryt Endo Inc	Terlipressin composition for use in treating ascites
US11033601B2 (en)	2017-09-14	2021-06-15	The Regents Of The University Of Colorado, A Body Corporate	Selective inhibition of V1b for treating fatty liver
CN109748950B (zh) *	2017-11-02	2020-10-30	深圳翰宇药业股份有限公司	一种固相合成血管升压素受体肽激动剂selepressin的方法
EP3517543B1 (en) *	2018-01-30	2020-11-04	Bachem AG	Manufacture of glucagon peptides
MX2021005693A (es)	2018-11-15	2021-07-07	Ferring Bv	Compuestos, composiciones y metodos para tratar la sepsis.
WO2024073445A1 (en) *	2022-09-30	2024-04-04	Ocelot Bio, Inc.	Mixed vasopressin receptor agonist-antagonist for modulating mean arterial pressure

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1076984A (en)	1963-04-05	1967-07-26	Sandoz Ltd	Improvements in or relating to local anaesthetics containing orn-vasopressin
NL129421C (pt)	1963-08-30	1900-01-01
CS235151B1 (cs)	1982-08-26	1985-05-15	Michal Lebl	Způsob dělení Dal isomerů analogů oxytocinu
US4829051A (en)	1983-04-05	1989-05-09	Vega Laboratories, Inc.	N-substituted derivatives of 1-desaminovasopressin
US4483794A (en)	1983-05-10	1984-11-20	Ceskoslovenska Akademie Ved	Analogs of neurohypophysial hormones
CS242062B1 (cs)	1984-08-23	1986-04-17	Milan Zaoral	Vasopresinová a vasotocinová analoga a způsob jejich přípravy
SE457055B (sv)	1986-08-18	1988-11-28	Ferring Ab	Topisk straalskyddsgel foer mukosa innehaallande kaerlsammandragande substanser
SE469473B (sv)	1987-10-07	1993-07-12	Ferring Ab	Vasoaktiva peptider
SE502644C2 (sv) *	1990-02-27	1995-11-27	Ferring Ab	Vasoaktiva vasotocinderivat
RU2063979C1 (ru)	1992-02-24	1996-07-20	Всесоюзный научно-исследовательский институт технологии кровезаменителей и гормональных препаратов	Пептиды последовательности окситоцина
US5516795A (en) *	1994-09-12	1996-05-14	Abbott Laboratories	Heteroatom substituted propanyl derivatives having 5-lipoxygenase inhibitory activity
RU2073010C1 (ru) *	1994-10-26	1997-02-10	Российско-германское совместное предприятие "Константа"	Способ синтеза лизин-вазопрессина в растворе
GB9617021D0 (en)	1996-08-13	1996-09-25	Salpep Biotechnology Inc	Novel peptides for treatment of inflammation and shock
SE9701161D0 (sv)	1997-03-27	1997-03-27	Karolinska Innovations Ab	New use I
SE9701162D0 (sv)	1997-03-27	1997-03-27	Karolinska Innovations Ab	New use II
AU9484798A (en)	1997-09-11	1999-03-29	Public Health Research Institute Of The City Of New York, Inc., The	Enhancement of mucosal antibody responses by interleukin-6
CA2321026A1 (en)	1998-03-09	1999-09-16	Zealand Pharmaceuticals A/S	Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
SE0001440D0 (sv)	2000-04-18	2000-04-18	Entretech Medical Ab	A drug against climacteric disorders
US20030109670A1 (en) *	2001-02-09	2003-06-12	University Of Utah Research Foundation	Cone snail peptides
WO2003082334A1 (fr) *	2002-03-29	2003-10-09	Wakamoto Pharmaceutical Co.,Ltd.	Medicaments pour augmenter la quantite de fluide lacrymal
US6861236B2 (en)	2002-05-24	2005-03-01	Applied Nanosystems B.V.	Export and modification of (poly)peptides in the lantibiotic way
AU2003279137A1 (en)	2002-10-03	2004-04-23	Neuropharmacology Services, Llc	Treatment of autism and similar disorders
US7183255B2 (en)	2003-02-26	2007-02-27	Intradialytic Pharmaceuticals	Method for stabilizing blood pressure in hemodialysis subjects
JO2937B1 (en) *	2004-08-11	2016-03-15	فيرينغ.بي.في	Tight muscles of the peptide vascular tensioner receptor
RU2415149C2 (ru) *	2006-02-10	2011-03-27	Ферринг Б.В.	Пептидные соединения
SI1984012T1 (sl) *	2006-02-13	2016-05-31	Ferring B.V.	Uporaba peptidnih agonistov receptorja vazopresina
AU2007338899A1 (en)	2006-12-20	2008-07-03	Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A.	Nucleoside cyclic phosphoramidates for the treatment of RNA-dependent RNA viral infection
RU2342949C1 (ru)	2007-03-26	2009-01-10	Юрий Георгиевич Жуковский	Применение [дезамино-1, изолейцин-3, аргинин-8]вазопрессина в качестве средства для увеличения выведения почкой солей натрия и усиления обратного избирательного всасывания из почечных канальцев в кровь воды-растворителя

2005
- 2005-07-17 JO JO2005102A patent/JO2937B1/en active
- 2005-07-19 TW TW094124322A patent/TWI364291B/zh not_active IP Right Cessation
- 2005-08-03 PT PT05783076T patent/PT1776133E/pt unknown
- 2005-08-03 KR KR1020067025140A patent/KR100884323B1/ko not_active Expired - Fee Related
- 2005-08-03 RU RU2007101238/04A patent/RU2355701C2/ru active
- 2005-08-03 WO PCT/US2005/027772 patent/WO2006020491A1/en not_active Ceased
- 2005-08-03 JP JP2007525670A patent/JP4664363B2/ja not_active Expired - Fee Related
- 2005-08-03 MX MX2007001396A patent/MX2007001396A/es active IP Right Grant
- 2005-08-03 BR BRPI0511466A patent/BRPI0511466B8/pt not_active IP Right Cessation
- 2005-08-03 DK DK05783076.2T patent/DK1776133T3/da active
- 2005-08-03 EP EP05783076A patent/EP1776133B1/en not_active Expired - Lifetime
- 2005-08-03 PL PL05783076T patent/PL1776133T3/pl unknown
- 2005-08-03 NZ NZ550707A patent/NZ550707A/en not_active IP Right Cessation
- 2005-08-03 AT AT05783076T patent/ATE509944T1/de active
- 2005-08-03 ES ES05783076T patent/ES2366702T3/es not_active Expired - Lifetime
- 2005-08-03 US US11/659,215 patent/US8148319B2/en active Active
- 2005-08-03 AU AU2005274070A patent/AU2005274070B2/en not_active Ceased
- 2005-08-03 SI SI200531312T patent/SI1776133T1/sl unknown
- 2005-08-03 CN CN2005800184358A patent/CN1964732B/zh not_active Expired - Fee Related
- 2005-08-03 CA CA2567797A patent/CA2567797C/en not_active Expired - Lifetime
- 2005-08-11 AR ARP050103332A patent/AR050914A1/es unknown
- 2005-08-13 SA SA5260254A patent/SA05260254B1/ar unknown
2006
- 2006-10-17 IL IL178690A patent/IL178690A/en active IP Right Grant
2007
- 2007-01-26 ZA ZA200700772A patent/ZA200700772B/xx unknown
- 2007-03-12 NO NO20071314A patent/NO342449B1/no not_active IP Right Cessation
2012
- 2012-03-01 US US13/409,976 patent/US8778881B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
SI1776133T1 (sl)	2011-07-29
CA2567797A1 (en)	2006-02-23
NO20071314L (no)	2007-05-10
US8778881B2 (en)	2014-07-15
EP1776133A1 (en)	2007-04-25
RU2007101238A (ru)	2008-09-20
CN1964732A (zh)	2007-05-16
US20120196808A1 (en)	2012-08-02
PL1776133T3 (pl)	2011-09-30
ES2366702T3 (es)	2011-10-24
ATE509944T1 (de)	2011-06-15
CN1964732B (zh)	2011-03-02
WO2006020491A1 (en)	2006-02-23
JP4664363B2 (ja)	2011-04-06
JO2937B1 (en)	2016-03-15
IL178690A (en)	2013-10-31
JP2008509221A (ja)	2008-03-27
AU2005274070A1 (en)	2006-02-23
BRPI0511466B1 (pt)	2018-01-23
TWI364291B (en)	2012-05-21
US8148319B2 (en)	2012-04-03
SA05260254B1 (ar)	2008-05-19
ZA200700772B (en)	2008-09-25
BRPI0511466A (pt)	2007-12-26
AR050914A1 (es)	2006-12-06
KR100884323B1 (ko)	2009-02-18
IL178690A0 (en)	2007-02-11
NZ550707A (en)	2010-07-30
HK1100280A1 (en)	2007-09-14
US20090054309A1 (en)	2009-02-26
NO342449B1 (no)	2018-05-22
MX2007001396A (es)	2007-04-19
RU2355701C2 (ru)	2009-05-20
EP1776133B1 (en)	2011-05-18
CA2567797C (en)	2012-07-10
DK1776133T3 (da)	2011-07-18
TW200612976A (en)	2006-05-01
BRPI0511466B8 (pt)	2021-05-25
AU2005274070B2 (en)	2008-02-07
KR20070029183A (ko)	2007-03-13
EP1776133A4 (en)	2008-12-31

Publication	Publication Date	Title
ZA200700772B (en)	2008-09-25	Peptidic vasopressin receptor agonists
TWI346553B (en)	2011-08-11	Chemokine receptor antagonists
ZA200705674B (en)	2009-08-26	Peptides with neuropeptide-2 receptor (Y2R) agonist activity
ZA200702128B (en)	2008-08-27	Interleukin-15 antagonist peptide
IL182355A0 (en)	2007-07-24	Thrombin receptor antagonists
IL189922A0 (en)	2008-08-07	Selective vpac2 receptor peptide agonists
ZA200700895B (en)	2016-07-27	Polypeptide
IL182024A0 (en)	2007-07-24	Peptide cyclisation
PL1984012T3 (pl)	2016-07-29	Zastosowanie peptydowych agonistów receptora wazopresyny
EP1874302A4 (en)	2009-12-16	ANTAGONISTS OF ANGIOTENSIN II RECEPTORS
IL189981A0 (en)	2008-08-07	Indol-3-yl-carbonyl-azaspiro derivatives as vasopressin receptor antagonists
ZA200610812B (en)	2008-06-25	Keratin-binding polypeptides
ZA200704526B (en)	2008-11-26	G Protein coupled receptor
GB0414798D0 (en)	2004-08-04	Receptor
GB0415196D0 (en)	2004-08-11	Polypeptide
GB0402904D0 (en)	2004-03-17	Polypeptide
ZA200702296B (en)	2008-10-29	Peptide cyclisation
GB0413872D0 (en)	2004-07-21	Receptor
GB0516946D0 (en)	2005-09-28	Receptor
GB0404584D0 (en)	2004-04-07	Receptor
GB0427025D0 (en)	2005-01-12	Receptor
GB0413096D0 (en)	2004-07-14	Receptor
GB0423327D0 (en)	2004-11-24	Receptor
GB0417119D0 (en)	2004-09-01	Receptor
GB0404309D0 (en)	2004-03-31	Receptor